封面
市場調查報告書
商品編碼
1193222

牲畜殺寄生蟲劑市場:按類型、牲畜、最終用戶分類:2021-2031 年全球機遇分析和行業預測

Livestock Parasiticides Market By Type , By Livestock, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日期: | 出版商: Allied Market Research | 英文 290 Pages | 商品交期: 2-3個工作天內

價格

家畜寄生蟲滅蟲劑市場規模到2021年將達到26.074億美元,2031年將達到48.55億美元,2022年至2031年CAGR 6.7 預計將創歷史新高。

家畜殺寄生蟲劑市場旨在提供控製家畜真菌和非細菌寄生蟲的化學品。 這些化學品一般配製成惰性成分,其中含有一種或多種活性成分。 許多殺寄生蟲劑的活性成分具有相似的化學結構,它們之間有許多共同的特徵。 此外,它們屬於不同的化學類別和家族。 牲畜寄生蟲劑對防治牲畜寄生蟲病的重要性已得到認可。 世界各地的許多主要參與者和公司都在家畜寄生蟲市場推出各種新配方和產品,以消除日益流行的食物中毒。

推動家畜寄生蟲滅殺劑市場增長的主要因素是全球動物保健意識的提高。 此外,隨著新興國家糧食生產所需的牲畜數量不斷增加,對動物保健品的需求也在增加。 它還發現 COVID-19 對牲畜殺寄生蟲劑市場的影響好壞參半。

對動物保健品的需求顯著下降。 畜牧業(主要是臨床製藥領域)的需求下降是由於世界各地持續實施的社會疏離準則導致獸醫診所就診次數減少。 然而,大流行期間對牲畜健康的日益擔憂最終導致市場需求增加。

家畜殺寄生蟲劑 全球家畜殺寄生蟲劑市場以北美為主,那裡的動物保健支出不斷增加,動物保健行業也很成熟。 另一方面,由於中國和印度等國家存在一些最大的動物養殖場,例如養豬場和家禽養殖場,預計亞太地區從 2022 年到 2031 年的複合年增長率將更快,達到 7.7%,最終導致區域市場的顯著增長。 由於牲畜數量的增加和動物源性食品消費的增加,拉丁美洲市場預計在未來將會增長。

越來越多的素食食品和飲食偏好以及對家畜殺蟲劑的限制和漫長的審批流程是影響全球家畜殺蟲劑市場的一些限制因素。它是 家畜寄生蟲控制市場分為類型、家畜、最終用戶和地區。 按類型分為殺外寄生蟲劑、殺內寄生蟲劑和殺內寄生蟲劑。 按牲畜類型劃分,市場分為牛、豬、家禽、綿羊和山羊。 按最終用戶劃分,可分為動物醫院/診所和動物養殖場。 按地區劃分,北美(美國、加拿大、墨西哥)、歐洲(英國、德國、法國、意大利、西班牙、荷蘭、瑞士、歐洲其他地區)、亞太地區(中國、日本、印度、韓國、澳大利亞、印度尼西亞、泰國)、亞太地區其他地區)和 LAMEA(南美洲)。

對利益相關者的主要好處

  • 本報告定量分析了 2021 年至 2031 年家畜寄生蟲市場分析的細分市場、當前趨勢、估計和動態,以確定家畜寄生蟲市場的主要機會。
  • 市場研究提供了與關鍵驅動因素、市場限制和機會相關的信息。
  • 波特的五力分析強調了買方和供應商在使利益相關者做出以利潤為導向的業務決策和加強供應商-買方網絡方面的潛力。
  • 對家畜寄生蟲滅蟲劑市場細分的詳細分析將有助於確定總體市場機會。
  • 每個地區的主要國家/地區是根據其對全球市場的收入貢獻繪製的。
  • 市場參與者定位有助於基準化,並提供對市場參與者當前位置的清晰瞭解。
  • 本報告分析了區域和全球家畜殺寄生蟲劑的市場趨勢、主要參與者、細分市場、應用和市場增長戰略。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析

第 4 章。家畜殺寄生蟲劑市場:按類型

  • 概覽
    • 市場規模和預測
  • 殺外寄生蟲劑
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區分類
  • 內部寄生蟲控製劑
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區分類
  • 殺寄生蟲劑
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區分類

第 5 章。牲畜殺寄生蟲劑市場:按牲畜分類

  • 概覽
    • 市場規模和預測
  • 奶牛
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區分類
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區分類
  • 家禽
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區分類
  • 綿羊/山羊
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區分類

第 6 章。家畜殺寄生蟲劑市場:按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 獸醫醫院和診所
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區分類
  • 動物農場
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區分類

第 7 章。家畜殺寄生蟲劑市場:按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機遇
    • 北美市場規模和預測:按類型
    • 北美市場規模和預測:按牲畜分類
    • 北美市場規模和預測:按最終用戶分類
    • 北美市場規模和預測:按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機遇
    • 歐洲市場規模和預測:按類型
    • 歐洲市場規模和預測:按牲畜分類
    • 歐洲市場規模和預測:按最終用戶分類
    • 歐洲市場規模和預測:按國家/地區分類
      • 英國
      • 意大利
      • 德國
      • 法國
      • 西班牙
      • 荷蘭
      • 瑞士
      • 其他歐洲
  • 亞太地區
    • 主要趨勢和機遇
    • 亞太市場規模和預測:按類型
    • 亞太市場規模和預測:按牲畜分類
    • 亞太市場規模和預測:按最終用戶分類
    • 亞太地區的市場規模和預測:按國家/地區分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 澳大利亞
      • 印度尼西亞
      • 泰國
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機遇
    • LAMEA 市場規模和預測:按類型
    • LAMEA 市場規模和預測:按牲畜分類
    • LAMEA 市場規模和預測:按最終用戶分類
    • LAMEA 市場規模和預測:按國家/地區分類
      • 拉丁美洲
      • 中東
      • 非洲

第八章公司情況

  • 簡介
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第九章公司簡介

  • Elanco Animal Health Incorporated
  • BOEHRINGER INGELHEIM GMBH
  • Zoetis Inc
  • MERCK & CO., INC
  • VIRBAC
  • VETOQUINOL S.A.
  • PETIQ, LLC
  • sequent scientific limited
  • KRKA GROUP
  • ECO ANIMAL HEALTH GROUP PLC
  • CEVA SANTE ANIMALE
  • CHANELLE PHARMA
  • BIMEDA ANIMAL HEALTH
  • NORBROOK
  • KYORITSU SEIYAKU CORPORATION
Product Code: A31345

The livestock parasiticides market size was valued at $2,607.4 million in 2021, and is projected to reach $4,855 million by 2031, registering a CAGR of 6.7% from 2022 to 2031. The livestock parasiticides market is meant to provide the chemical substances that remove parasites other than fungi and bacteria in livestock. These chemicals are generally inert ingredients that are made in a formulation and consist of one or more than one active ingredient in it. Most of the parasiticidal have active ingredients, which have similar chemical structures and have many of the common features among them. They are grouped into different chemical classes and families as well. The importance of the livestock parasiticides has been recognized for the protection and the cure of parasitic diseases in the animal. Many key players and the companies throughout the world are coming up with various new formulations and the products in the livestock parasiticides market to remove the increasing prevalence of the foodborne diseases.

The major factors that drive the growth of the livestock parasiticides market are increasing awareness about animal healthcare worldwide. Moreover, the escalating number of livestock animals for the purpose of food production in the emerging economies is leading to rising demand for animal healthcare products. And surge in the animal healthcare expenditure for animal welfare to improve their health of livestock animals further fuels the overall livestock parasiticides market.It was also found that there was mixed impact of COVID-19 on livestock parasiticides market.

There was significant decline in the demand for animal health products. The decline in demand for livestock business primarily in clinical administrator pharmaceuticals segment was due to social distancing guidelines followed across the globe led to decrease in veterinary clinical visit.. However, the rising concern about the livestock health during the pandemic ultimately led to increase in market demand.

The market in North America dominates the global livestock parasiticides market due to its well-established base of animal health industry along with rise in expenditure on animal healthcare. Whereas Asia-Pacific is expected to grow at a faster CAGR of 7.7% from 2022 to 2031, due to the presence of some of the largest animal farms such as pigs and the poultry farms in the countries such as China and India and this ultimately results in the substantial growth of the market in the region. The market in Latin America is expected to grow in upcoming future due to rise in population of livestock animals and increase in consumption of animal derived food products in the region.

A growth in preference for vegetarian food & diet coupled with the restrictions and the long approval process for livestock parasiticides for livestock animals are some of the restraints affecting the global livestock parasiticides market. The livestock parasiticides market is segmented into type, livestock, end user, and region. On the basis of type, the market is fragmented into ectoparasiticides, endoparasiticides , and endectocides. On the basis of livestock, the market is categorized into cattle, pigs, poultry, sheep, and goats. On the basis of end user, the market is bifurcated into veterinary clinics & hospitals and animal farms. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, The Netherlands , Switzerland and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Thailand, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, & Africa).

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the livestock parasiticides market analysis from 2021 to 2031 to identify the prevailing livestock parasiticides market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the livestock parasiticides market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global livestock parasiticides market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type 

  • Ectoparasiticides 
  • Endoparasiticides 
  • Endectocides

By Livestock

  • Poultry
  • Sheep and goats
  • Cattle
  • Pigs

By End user

  • Veterinary clinics and hospitals
  • Animal farms

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Italy
    • Germany
    • France
    • Spain
    • The Netherlands
    • Switzerland
    • Rest Of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand 
    • Rest Of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
  • Key Market Players
    • Elanco
    • C.H. Boehringer Sohn AG & Co. KG.
    • Zoetis
    • Merck & Co., Inc.
    • Virbac
    • Vetoquinol
    • PETIQ, LLC
    • SeQuent
    • Krka
    • ECO Animal Health Ltd
    • Ceva
    • Chanelle Pharma
    • Bimeda, Inc.
    • Norbrook
    • Kyoritsuseiyaku

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: LIVESTOCK PARASITICIDES MARKET, BY TYPE 

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Ectoparasiticides 
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Endoparasiticides 
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Endectocides
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country

CHAPTER 5: LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Cattle
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Pigs
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Poultry
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Sheep and goats
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: LIVESTOCK PARASITICIDES MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Veterinary clinics and hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Animal farms
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country

CHAPTER 7: LIVESTOCK PARASITICIDES MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type 
    • 7.2.3 North America Market size and forecast, by Livestock
    • 7.2.4 North America Market size and forecast, by End user
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type 
      • 7.2.5.1.2 Market size and forecast, by Livestock
      • 7.2.5.1.3 Market size and forecast, by End user
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type 
      • 7.2.5.2.2 Market size and forecast, by Livestock
      • 7.2.5.2.3 Market size and forecast, by End user
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type 
      • 7.2.5.3.2 Market size and forecast, by Livestock
      • 7.2.5.3.3 Market size and forecast, by End user
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type 
    • 7.3.3 Europe Market size and forecast, by Livestock
    • 7.3.4 Europe Market size and forecast, by End user
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 UK
      • 7.3.5.1.1 Market size and forecast, by Type 
      • 7.3.5.1.2 Market size and forecast, by Livestock
      • 7.3.5.1.3 Market size and forecast, by End user
      • 7.3.5.2 Italy
      • 7.3.5.2.1 Market size and forecast, by Type 
      • 7.3.5.2.2 Market size and forecast, by Livestock
      • 7.3.5.2.3 Market size and forecast, by End user
      • 7.3.5.3 Germany
      • 7.3.5.3.1 Market size and forecast, by Type 
      • 7.3.5.3.2 Market size and forecast, by Livestock
      • 7.3.5.3.3 Market size and forecast, by End user
      • 7.3.5.4 France
      • 7.3.5.4.1 Market size and forecast, by Type 
      • 7.3.5.4.2 Market size and forecast, by Livestock
      • 7.3.5.4.3 Market size and forecast, by End user
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type 
      • 7.3.5.5.2 Market size and forecast, by Livestock
      • 7.3.5.5.3 Market size and forecast, by End user
      • 7.3.5.6 The Netherlands
      • 7.3.5.6.1 Market size and forecast, by Type 
      • 7.3.5.6.2 Market size and forecast, by Livestock
      • 7.3.5.6.3 Market size and forecast, by End user
      • 7.3.5.7 Switzerland
      • 7.3.5.7.1 Market size and forecast, by Type 
      • 7.3.5.7.2 Market size and forecast, by Livestock
      • 7.3.5.7.3 Market size and forecast, by End user
      • 7.3.5.8 Rest of Europe
      • 7.3.5.8.1 Market size and forecast, by Type 
      • 7.3.5.8.2 Market size and forecast, by Livestock
      • 7.3.5.8.3 Market size and forecast, by End user
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type 
    • 7.4.3 Asia-Pacific Market size and forecast, by Livestock
    • 7.4.4 Asia-Pacific Market size and forecast, by End user
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Type 
      • 7.4.5.1.2 Market size and forecast, by Livestock
      • 7.4.5.1.3 Market size and forecast, by End user
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Type 
      • 7.4.5.2.2 Market size and forecast, by Livestock
      • 7.4.5.2.3 Market size and forecast, by End user
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Type 
      • 7.4.5.3.2 Market size and forecast, by Livestock
      • 7.4.5.3.3 Market size and forecast, by End user
      • 7.4.5.4 South Korea
      • 7.4.5.4.1 Market size and forecast, by Type 
      • 7.4.5.4.2 Market size and forecast, by Livestock
      • 7.4.5.4.3 Market size and forecast, by End user
      • 7.4.5.5 Australia
      • 7.4.5.5.1 Market size and forecast, by Type 
      • 7.4.5.5.2 Market size and forecast, by Livestock
      • 7.4.5.5.3 Market size and forecast, by End user
      • 7.4.5.6 Indonesia
      • 7.4.5.6.1 Market size and forecast, by Type 
      • 7.4.5.6.2 Market size and forecast, by Livestock
      • 7.4.5.6.3 Market size and forecast, by End user
      • 7.4.5.7 Thailand 
      • 7.4.5.7.1 Market size and forecast, by Type 
      • 7.4.5.7.2 Market size and forecast, by Livestock
      • 7.4.5.7.3 Market size and forecast, by End user
      • 7.4.5.8 Rest of Asia-Pacific
      • 7.4.5.8.1 Market size and forecast, by Type 
      • 7.4.5.8.2 Market size and forecast, by Livestock
      • 7.4.5.8.3 Market size and forecast, by End user
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type 
    • 7.5.3 LAMEA Market size and forecast, by Livestock
    • 7.5.4 LAMEA Market size and forecast, by End user
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Latin America
      • 7.5.5.1.1 Market size and forecast, by Type 
      • 7.5.5.1.2 Market size and forecast, by Livestock
      • 7.5.5.1.3 Market size and forecast, by End user
      • 7.5.5.2 Middle East
      • 7.5.5.2.1 Market size and forecast, by Type 
      • 7.5.5.2.2 Market size and forecast, by Livestock
      • 7.5.5.2.3 Market size and forecast, by End user
      • 7.5.5.3 Africa
      • 7.5.5.3.1 Market size and forecast, by Type 
      • 7.5.5.3.2 Market size and forecast, by Livestock
      • 7.5.5.3.3 Market size and forecast, by End user

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Elanco Animal Health Incorporated
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 BOEHRINGER INGELHEIM GMBH
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Zoetis Inc
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4  MERCK & CO., INC
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 VIRBAC
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 VETOQUINOL S.A.
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 PETIQ, LLC
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 sequent scientific limited
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 KRKA GROUP
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 ECO ANIMAL HEALTH GROUP PLC
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
  • 9.11  CEVA SANTE ANIMALE
    • 9.11.1 Company overview
    • 9.11.2 Company snapshot
    • 9.11.3 Operating business segments
    • 9.11.4 Product portfolio
    • 9.11.5 Business performance
    • 9.11.6 Key strategic moves and developments
  • 9.12 CHANELLE PHARMA
    • 9.12.1 Company overview
    • 9.12.2 Company snapshot
    • 9.12.3 Operating business segments
    • 9.12.4 Product portfolio
    • 9.12.5 Business performance
    • 9.12.6 Key strategic moves and developments
  • 9.13  BIMEDA ANIMAL HEALTH
    • 9.13.1 Company overview
    • 9.13.2 Company snapshot
    • 9.13.3 Operating business segments
    • 9.13.4 Product portfolio
    • 9.13.5 Business performance
    • 9.13.6 Key strategic moves and developments
  • 9.14 NORBROOK
    • 9.14.1 Company overview
    • 9.14.2 Company snapshot
    • 9.14.3 Operating business segments
    • 9.14.4 Product portfolio
    • 9.14.5 Business performance
    • 9.14.6 Key strategic moves and developments
  • 9.15 KYORITSU SEIYAKU CORPORATION
    • 9.15.1 Company overview
    • 9.15.2 Company snapshot
    • 9.15.3 Operating business segments
    • 9.15.4 Product portfolio
    • 9.15.5 Business performance
    • 9.15.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 2. LIVESTOCK PARASITICIDES MARKET, FOR ECTOPARASITICIDES , BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. LIVESTOCK PARASITICIDES MARKET FOR ECTOPARASITICIDES , BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. LIVESTOCK PARASITICIDES MARKET, FOR ENDOPARASITICIDES , BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. LIVESTOCK PARASITICIDES MARKET FOR ENDOPARASITICIDES , BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. LIVESTOCK PARASITICIDES MARKET, FOR ENDECTOCIDES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. LIVESTOCK PARASITICIDES MARKET FOR ENDECTOCIDES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. GLOBAL LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 9. LIVESTOCK PARASITICIDES MARKET, FOR CATTLE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. LIVESTOCK PARASITICIDES MARKET FOR CATTLE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. LIVESTOCK PARASITICIDES MARKET, FOR PIGS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. LIVESTOCK PARASITICIDES MARKET FOR PIGS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. LIVESTOCK PARASITICIDES MARKET, FOR POULTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. LIVESTOCK PARASITICIDES MARKET FOR POULTRY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. LIVESTOCK PARASITICIDES MARKET, FOR SHEEP AND GOATS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. LIVESTOCK PARASITICIDES MARKET FOR SHEEP AND GOATS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. GLOBAL LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 18. LIVESTOCK PARASITICIDES MARKET, FOR VETERINARY CLINICS AND HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. LIVESTOCK PARASITICIDES MARKET FOR VETERINARY CLINICS AND HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. LIVESTOCK PARASITICIDES MARKET, FOR ANIMAL FARMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. LIVESTOCK PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. LIVESTOCK PARASITICIDES MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 23. NORTH AMERICA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 24. NORTH AMERICA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 25. NORTH AMERICA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 26. NORTH AMERICA LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. U.S. LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 28. U.S. LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 29. U.S. LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 30. CANADA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 31. CANADA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 32. CANADA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 33. MEXICO LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 34. MEXICO LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 35. MEXICO LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 36. EUROPE LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 37. EUROPE LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 38. EUROPE LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 39. EUROPE LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 40. UK LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 41. UK LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 42. UK LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 43. ITALY LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 44. ITALY LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 45. ITALY LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 46. GERMANY LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 47. GERMANY LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 48. GERMANY LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 50. FRANCE LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 51. FRANCE LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 52. SPAIN LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 53. SPAIN LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 54. SPAIN LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. THE NETHERLANDS LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 56. THE NETHERLANDS LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 57. THE NETHERLANDS LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 58. SWITZERLAND LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 59. SWITZERLAND LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 60. SWITZERLAND LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 63. REST OF EUROPE LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 68. CHINA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 69. CHINA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 70. CHINA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 71. JAPAN LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 72. JAPAN LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 73. JAPAN LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 74. INDIA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 75. INDIA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 76. INDIA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. SOUTH KOREA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 78. SOUTH KOREA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 79. SOUTH KOREA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 80. AUSTRALIA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 81. AUSTRALIA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 82. AUSTRALIA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 83. INDONESIA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 84. INDONESIA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 85. INDONESIA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 86. THAILAND  LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 87. THAILAND  LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 88. THAILAND  LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 92. LAMEA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 93. LAMEA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 94. LAMEA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 95. LAMEA LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 96. LATIN AMERICA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 97. LATIN AMERICA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 98. LATIN AMERICA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 99. MIDDLE EAST LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 100. MIDDLE EAST LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 101. MIDDLE EAST LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 102. AFRICA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 103. AFRICA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 104. AFRICA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 105.ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT
  • TABLE 106.ELANCO ANIMAL HEALTH INCORPORATED: OPERATING SEGMENTS
  • TABLE 107.ELANCO ANIMAL HEALTH INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 108.ELANCO ANIMAL HEALTH INCORPORATED: NET SALES,
  • TABLE 109.ELANCO ANIMAL HEALTH INCORPORATED: KEY STRATERGIES
  • TABLE 110.BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT
  • TABLE 111.BOEHRINGER INGELHEIM GMBH: OPERATING SEGMENTS
  • TABLE 112.BOEHRINGER INGELHEIM GMBH: PRODUCT PORTFOLIO
  • TABLE 113.BOEHRINGER INGELHEIM GMBH: NET SALES,
  • TABLE 114.BOEHRINGER INGELHEIM GMBH: KEY STRATERGIES
  • TABLE 115.ZOETIS INC: COMPANY SNAPSHOT
  • TABLE 116.ZOETIS INC: OPERATING SEGMENTS
  • TABLE 117.ZOETIS INC: PRODUCT PORTFOLIO
  • TABLE 118.ZOETIS INC: NET SALES,
  • TABLE 119.ZOETIS INC: KEY STRATERGIES
  • TABLE 120. MERCK & CO., INC: COMPANY SNAPSHOT
  • TABLE 121. MERCK & CO., INC: OPERATING SEGMENTS
  • TABLE 122. MERCK & CO., INC: PRODUCT PORTFOLIO
  • TABLE 123. MERCK & CO., INC: NET SALES,
  • TABLE 124. MERCK & CO., INC: KEY STRATERGIES
  • TABLE 125.VIRBAC: COMPANY SNAPSHOT
  • TABLE 126.VIRBAC: OPERATING SEGMENTS
  • TABLE 127.VIRBAC: PRODUCT PORTFOLIO
  • TABLE 128.VIRBAC: NET SALES,
  • TABLE 129.VIRBAC: KEY STRATERGIES
  • TABLE 130.VETOQUINOL S.A.: COMPANY SNAPSHOT
  • TABLE 131.VETOQUINOL S.A.: OPERATING SEGMENTS
  • TABLE 132.VETOQUINOL S.A.: PRODUCT PORTFOLIO
  • TABLE 133.VETOQUINOL S.A.: NET SALES,
  • TABLE 134.VETOQUINOL S.A.: KEY STRATERGIES
  • TABLE 135.PETIQ, LLC: COMPANY SNAPSHOT
  • TABLE 136.PETIQ, LLC: OPERATING SEGMENTS
  • TABLE 137.PETIQ, LLC: PRODUCT PORTFOLIO
  • TABLE 138.PETIQ, LLC: NET SALES,
  • TABLE 139.PETIQ, LLC: KEY STRATERGIES
  • TABLE 140.SEQUENT SCIENTIFIC LIMITED: COMPANY SNAPSHOT
  • TABLE 141.SEQUENT SCIENTIFIC LIMITED: OPERATING SEGMENTS
  • TABLE 142.SEQUENT SCIENTIFIC LIMITED: PRODUCT PORTFOLIO
  • TABLE 143.SEQUENT SCIENTIFIC LIMITED: NET SALES,
  • TABLE 144.SEQUENT SCIENTIFIC LIMITED: KEY STRATERGIES
  • TABLE 145.KRKA GROUP: COMPANY SNAPSHOT
  • TABLE 146.KRKA GROUP: OPERATING SEGMENTS
  • TABLE 147.KRKA GROUP: PRODUCT PORTFOLIO
  • TABLE 148.KRKA GROUP: NET SALES,
  • TABLE 149.KRKA GROUP: KEY STRATERGIES
  • TABLE 150.ECO ANIMAL HEALTH GROUP PLC: COMPANY SNAPSHOT
  • TABLE 151.ECO ANIMAL HEALTH GROUP PLC: OPERATING SEGMENTS
  • TABLE 152.ECO ANIMAL HEALTH GROUP PLC: PRODUCT PORTFOLIO
  • TABLE 153.ECO ANIMAL HEALTH GROUP PLC: NET SALES,
  • TABLE 154.ECO ANIMAL HEALTH GROUP PLC: KEY STRATERGIES
  • TABLE 155. CEVA SANTE ANIMALE: COMPANY SNAPSHOT
  • TABLE 156. CEVA SANTE ANIMALE: OPERATING SEGMENTS
  • TABLE 157. CEVA SANTE ANIMALE: PRODUCT PORTFOLIO
  • TABLE 158. CEVA SANTE ANIMALE: NET SALES,
  • TABLE 159. CEVA SANTE ANIMALE: KEY STRATERGIES
  • TABLE 160.CHANELLE PHARMA: COMPANY SNAPSHOT
  • TABLE 161.CHANELLE PHARMA: OPERATING SEGMENTS
  • TABLE 162.CHANELLE PHARMA: PRODUCT PORTFOLIO
  • TABLE 163.CHANELLE PHARMA: NET SALES,
  • TABLE 164.CHANELLE PHARMA: KEY STRATERGIES
  • TABLE 165. BIMEDA ANIMAL HEALTH: COMPANY SNAPSHOT
  • TABLE 166. BIMEDA ANIMAL HEALTH: OPERATING SEGMENTS
  • TABLE 167. BIMEDA ANIMAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 168. BIMEDA ANIMAL HEALTH: NET SALES,
  • TABLE 169. BIMEDA ANIMAL HEALTH: KEY STRATERGIES
  • TABLE 170.NORBROOK: COMPANY SNAPSHOT
  • TABLE 171.NORBROOK: OPERATING SEGMENTS
  • TABLE 172.NORBROOK: PRODUCT PORTFOLIO
  • TABLE 173.NORBROOK: NET SALES,
  • TABLE 174.NORBROOK: KEY STRATERGIES
  • TABLE 175.KYORITSU SEIYAKU CORPORATION: COMPANY SNAPSHOT
  • TABLE 176.KYORITSU SEIYAKU CORPORATION: OPERATING SEGMENTS
  • TABLE 177.KYORITSU SEIYAKU CORPORATION: PRODUCT PORTFOLIO
  • TABLE 178.KYORITSU SEIYAKU CORPORATION: NET SALES,
  • TABLE 179.KYORITSU SEIYAKU CORPORATION: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.LIVESTOCK PARASITICIDES MARKET SEGMENTATION
  • FIGURE 2.LIVESTOCK PARASITICIDES MARKET,2021-2031
  • FIGURE 3.LIVESTOCK PARASITICIDES MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.LIVESTOCK PARASITICIDES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.LIVESTOCK PARASITICIDES MARKET,BY TYPE ,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ECTOPARASITICIDES  LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ENDOPARASITICIDES  LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF ENDECTOCIDES LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 16.LIVESTOCK PARASITICIDES MARKET,BY LIVESTOCK,2021(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CATTLE LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF PIGS LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF POULTRY LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF SHEEP AND GOATS LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 21.LIVESTOCK PARASITICIDES MARKET,BY END USER,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF VETERINARY CLINICS AND HOSPITALS LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ANIMAL FARMS LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 24.LIVESTOCK PARASITICIDES MARKET BY REGION,2021
  • FIGURE 25.U.S. LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 26.CANADA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 27.MEXICO LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 28.UK LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 29.ITALY LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 30.GERMANY LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 31.FRANCE LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 32.SPAIN LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 33.THE NETHERLANDS LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 34.SWITZERLAND LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF EUROPE LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 36.CHINA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 37.JAPAN LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 38.INDIA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 39.SOUTH KOREA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 40.AUSTRALIA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 41.INDONESIA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 42.THAILAND  LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 43.REST OF ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 44.LATIN AMERICA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 45.MIDDLE EAST LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 46.AFRICA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 50.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 51.COMPETITIVE DASHBOARD
  • FIGURE 52.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 53.ELANCO ANIMAL HEALTH INCORPORATED.: NET SALES ,($MILLION)
  • FIGURE 54.BOEHRINGER INGELHEIM GMBH.: NET SALES ,($MILLION)
  • FIGURE 55.ZOETIS INC.: NET SALES ,($MILLION)
  • FIGURE 56. MERCK & CO., INC.: NET SALES ,($MILLION)
  • FIGURE 57.VIRBAC.: NET SALES ,($MILLION)
  • FIGURE 58.VETOQUINOL S.A..: NET SALES ,($MILLION)
  • FIGURE 59.PETIQ, LLC.: NET SALES ,($MILLION)
  • FIGURE 60.SEQUENT SCIENTIFIC LIMITED.: NET SALES ,($MILLION)
  • FIGURE 61.KRKA GROUP.: NET SALES ,($MILLION)
  • FIGURE 62.ECO ANIMAL HEALTH GROUP PLC.: NET SALES ,($MILLION)
  • FIGURE 63. CEVA SANTE ANIMALE.: NET SALES ,($MILLION)
  • FIGURE 64.CHANELLE PHARMA.: NET SALES ,($MILLION)
  • FIGURE 65. BIMEDA ANIMAL HEALTH.: NET SALES ,($MILLION)
  • FIGURE 66.NORBROOK.: NET SALES ,($MILLION)
  • FIGURE 67.KYORITSU SEIYAKU CORPORATION.: NET SALES ,($MILLION)